Meta-analysis of 11 studies (11,487 adults with ulcerative colitis escalated to advanced therapy): continuing 5-ASA vs stopping was associated with lower odds of clinical remission (aOR 0.72), with no differences in secondary or safety outcomes.
Meta-analysisn = 11,487
Sul et al. Efficacy of 5-aminosalicylic acid continuation versus discontinuation in patients with ulcerative colitis escalated to advanced therapy: a systematic review and meta-analysis of adjusted effect estimates